Multiple cell cycle proteins (RB1, p53, BRCA1 and BRCA2) and survival signaling pathways (PTEN and PIK3CA) are involved in BC and can affect the response to treatment [43,44]. The gene discussed is BRCA2; the disease is breast cancer.